This inventor holds 1 USPTO granted patent. Top assignee: Rudjer Boskovic Institute. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Marijan Kocevar: Innovator in Tumor Treatment
Introduction
Marijan Kocevar is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of tumors. His innovative work has led to the development of compounds that show promise in cancer therapy.
Latest Patents
Marijan Kocevar holds a patent for "Analogues of 1,3-bis(4-nitrophenyl)triazenes, their pharmaceutically acceptable salts and N-acyl derivatives for tumour treatment." This invention refers to analogues of 1,3-bis(4-nitrophenyl)triazenes, which exhibit cytotoxicity at very low concentrations (IC0.22 to 12.8 µM) and demonstrate good solubility. These compounds can be utilized in the treatment of tumor patients either as standalone drugs or in combination with other cytostatics. He has 1 patent to his name.
Career Highlights
Marijan Kocevar is affiliated with the Ruđer Bošković Institute, where he conducts his research and development work. His career has been marked by a commitment to advancing medical treatments and improving patient outcomes.
Collaborations
Throughout his career, Marijan has collaborated with esteemed colleagues, including Maja Osmak and Slovenko Polanc. These partnerships have contributed to the success of his research endeavors.
Conclusion
Marijan Kocevar's innovative work in the field of tumor treatment exemplifies the impact of dedicated research on healthcare. His contributions continue to pave the way for advancements in cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile